1. A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy. (March 2021) Authors: Frazzoni, L.; Sikandar, U.; Mazzella, G.; Fuccio, L.; Bazzoli, F.; Brillanti, S.; Azzaroli, F. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice. (10th February 2016) Authors: Conti, F.; Scuteri, A.; Vitale, G.; Lazzarini, G.; Porro, A.; Muratori, P.; Serio, I.; Buonfiglioli, F.; Badia, L.; Lanzi, A.; Mastroroberto, M.; Appolloni, L.; Morotti, M.; Morelli, M.C.; Foschi, F.G.; Verucchi, G.; Brillanti, S.; Crespi, C.; Lenzi, M.; Mazzella, G. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Issue 1 (February 2018) Authors: Gardini, A.C.; Foschi, F.G.; Conti, F.; Petracci, E.; Marisi, G.; Buonfiglioli, F.; Ravaioli, M.; Mazzella, G.; Muratori, P.; Lenzi, M.; Crespi, C.; Bolondi, L.; Badia, L.; Verucchi, G.; Vitale, G.; Vukotic, R.; Brillanti, S.; Andreone, P. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients. (February 2019) Authors: Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti, S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients. Issue 1 (16th February 2017) Authors: Ravaioli, F.; Mazzella, G.; Andreone, P.; Conti, F.; Brillanti, S.; Buonfiglioli, F.; Serio, I.; Verucchi, G.; Bacchi Reggiani, M.L.; Marasco, G.; Colecchia, A.; Festi, D. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P.04.2 THE RISK OF HEPATIC DECOMPENSATION IS REDUCED, BUT NOT ABOLISHED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT. (25th March 2019) Authors: Dajti, E.; Ravaioli, F.; Colecchia, A.; Reggiani, M.L. Bacchi; Marasco, G.; Alemanni, L.V.; Tamè, M.; Azzaroli, F.; Brillanti, S.; Mazzella, G.; Festi, D. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Presence of resistance associated variants in patients with virological failure to new direct acting antivirals and requirement of unconventional regimens for re-treatment. (10th February 2016) Authors: Di Maio, V.C.; Cento, V.; Di Paolo, D.; Lenci, I.; Aragri, M.; Verucchi, G.; Melis, M.; Bertoli, A.; Antonucci, F.P.; Francioso, S.; Pellicelli, A.; Calvaruso, V.; Pasquazzi, C.; Romagnoli, D.; Rosa, K. Yu La; Campoli, R.; Biolato, M.; Vecchiet, J.; Sorbo, M.C.; Morisco, F. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 1 Page Start: e3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prospective study on the prevalence of HCV infection in consecutive adult inpatients in a hospital division of Internal Medicine in Tuscany. (March 2023) Authors: Pacini, S.; Capecchi, P.L.; Brillanti, S. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety and efficacy of direct‐acting antivirals for the treatment of chronic hepatitis C in a real‐world population aged 65 years and older. Issue 6 (2nd February 2017) Authors: Conti, F.; Brillanti, S.; Buonfiglioli, F.; Vukotic, R.; Morelli, M. C.; Lalanne, C.; Massari, M.; Foschi, F. G.; Bernabucci, V.; Serio, I.; Prati, G. M.; Negri, E.; Badia, L.; Caraceni, P.; Muratori, P.; Vitale, G.; Porro, A.; Morotti, M.; Mazzella, G.; Andreone, P. Journal: Journal of viral hepatitis Issue: Volume 24:Issue 6(2017) Page Start: 454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests. (March 2021) Authors: Alterini, G.; Sacco, P.; Formichi, C.; Ciuoli, C.; Ceccarelli, E.; Gonnelli, S.; Volterrani, L.; Castagna, M.G.; Dotta, F.; Brillanti, S. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗